Linoject

Application area

Treatment of infectious and inflammatory diseases, if known or suspected to be caused by linezolid-sensitive aerobic and anaerobic Gram-positive microorganisms (including infections accompanied by bacteremia):

• community-acquired pneumonia caused by Streptococcus pneumoniae (including multiresistant strains), including cases accompanied by bacteremia or Staphylococcus aureus (methicillin-sensitive strains only);

• hospital pneumonia caused by Staphylococcus aureus (including methicillin-sensitive and methicillin-resistant strains) or Streptococcus pneumoniae (including multiresistant strains);

• complicated skin and soft tissue infections, including diabetic foot syndrome infections without osteomyelitis, caused by Staphylococcus aureus (including methicillin-sensitive and methicillin-resistant strains), Streptococcus pyogenes or Streptococcus agalactiae;

• infections caused by vancomycin-resistant Enterococcus faecalis, including those accompanied by bacteremia.